Bacteriologically confirmed tuberculosis in HIV-infected infants: Disease spectrum and survival

International Journal of Tuberculosis and Lung Disease

Volumn 15, Issue 6, 2011, Pages

  Wiseman, C A ^a   Schaaf, H S ^a   Cotton, M F ^b   Gie, R P ^a   Jennings, T ^a   Whitelaw, A ^c,d   Roux, P ^e   Hesseling, A C ^a  

^a STELLENBOSCH UNIVERSITY   (South Africa)

^b STELLENBOSCH UNIVERSITY   (South Africa)

^c UNIVERSITY OF CAPE TOWN   (South Africa)

^d NATIONAL HEALTH LABORATORY SERVICE   (South Africa)

^e UNIVERSITY OF CAPE TOWN   (South Africa)

Author keywords

Disease spectrum; HIV; Infants; Mortality; TB

Indexed keywords

ANTIRETROVIRUS AGENT; ETHAMBUTOL; ETHIONAMIDE; ISONIAZID; PYRAZINAMIDE; RIFAMPICIN;

ARTICLE; CD4+ T LYMPHOCYTE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE SEVERITY; EXTRAPULMONARY TUBERCULOSIS; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFANT; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; MILIARY TUBERCULOSIS; MIXED INFECTION; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SURVIVAL RATE; THORAX RADIOGRAPHY; TREATMENT RESPONSE;

AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTI-RETROVIRAL AGENTS; ANTITUBERCULAR AGENTS; FEMALE; HIV INFECTIONS; HUMANS; INFANT; INFANT, NEWBORN; MALE; MYCOBACTERIUM TUBERCULOSIS; POLYMERASE CHAIN REACTION; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; SOUTH AFRICA; SPUTUM; SURVIVAL ANALYSIS; TUBERCULOSIS; TUBERCULOSIS VACCINES;

EID: 79955865881     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: 10.5588/ijtld.10.0501     Document Type: Article

References (36)

1. World Health Organization. Global tuberculosis control: a short update to the 2009 report. WHO/HTM/TB/2009.426. Geneva, Switzerland: WHO, 2010. http://whqlibdoc.who.int/ publications/2009/9789241598866-eng.pdf Accessed March 2011.
2. Starke J R. Pediatric tuberculosis: time for a new approach. Tuberculosis (Edinb) 2003; 83: 208-212. (Pubitemid 36683573)
3. Cotton M F, Schaaf H S, Hesseling A C, Madhi S A. HIV and childhood tuberculosis: the way forward. Int J Tuberc Lung Dis 2004; 8: 675-682. (Pubitemid 38625079)
4. Zar H J, Hanslo D, Apolles P, Swingler G, Hussey G. Induced sputum versus gastric lavage for microbiological confirmation of pulmonary tuberculosis in infants and young children: a prospective study. Lancet 2005; 365: 130-134. (Pubitemid 40091802)
5. Corbett E L, Watt C J, Walker N, et al. The growing burden of tuberculosis: global trends and interactions with the HIV epidemic. Arch Intern Med 2003; 163: 1009-1021. (Pubitemid 36548927)
6. Pillay T, Khan M, Moodley J, et al. The increasing burden of tuberculosis in pregnant women, newborns and infants under six months of age in Durban, KwaZulu Natal. S Afr Med J 2001; 91: 983-986.
7. Khan M, Pillay T, Moodley J M, Connolly CA. Maternal mortality associated with tuberculosis-HIV-1 co-infection in Durban, South Africa. AIDS 2001; 15: 1857-1863. (Pubitemid 32939248)
8. Hesseling A C, Cotton M F, Jennings T, et al. High incidence of tuberculosis among HIV-infected infants: evidence from a South African population-based study highlights the need for improved tuberculosis control strategies. Clin Infect Dis 2009; 48: 108-114.
9. Cotton M F, Schaaf H S, Lottering G, Weber H L, Coetzee J, Nachman S. Tuberculosis exposure in HIV-exposed infants in a high-prevalence setting. Int J Tuberc Lung Dis 2008; 12: 225-227. (Pubitemid 351212418)
10. Mansoor N, Scriba T J, de Kock M, et al. HIV-1 infection in infants severely impairs the immune response induced by bacille Calmette-Guerin vaccine. J Infect Dis 2009; 199: 982-990.
11. Bucher H C, Griffith L E, Guyatt G H, et al. Isoniazid prophylaxis for tuberculosis in HIV infection: a meta-analysis of randomized controlled trials. AIDS 1999; 13: 501-507.
12. Mukadi Y D, Wiktor S Z, Coulibaly I M, et al. Impact of HIV infection on the development, clinical presentation, and outcome of tuberculosis among children in Abidjan, Cote d'Ivoire. AIDS 1997; 11: 1151-1158. (Pubitemid 27273613)
13. Palme I B, Gudetta B, Bruchfeld J, Muhe L, Giesecke J. Impact of human immunodeficiency virus 1 infection on clinical presentation, treatment outcome and survival in a cohort of Ethiopian children with tuberculosis. Pediatr Infect Dis J 2002; 21: 1053-1061. (Pubitemid 35334515)
14. Marais B J, Gie R P, Schaaf H S, et al. The natural history of childhood intra-thoracic tuberculosis: a critical review of literature from the pre-chemotherapy era. Int J Tuberc Lung Dis 2004; 8: 392-402. (Pubitemid 38624845)
15. Schaaf H S, Marais B J, Whitelaw A, et al. Culture-confirmed childhood tuberculosis in Cape Town, South Africa: a review of 596 cases. BMC Infect Dis 2007; 7: 140.
16. Marais B J, Donald P R, Gie R P, Schaaf H S, Beyers N. Diversity of disease in childhood pulmonary tuberculosis. Ann Trop Paediatr 2005; 25: 79-86. (Pubitemid 41131125)
17. Madhi S A, Huebner R E, Doedens L, Aduc T, Wesley D, Cooper P A. HIV-1 co-infection in children hospitalised with tuberculosis in South Africa. Int J Tuberc Lung Dis 2000; 4: 448-454. (Pubitemid 30256848)
18. Webb E A, Hesseling A C, Schaaf H S, et al. High prevalence of Mycobacterium tuberculosis infection and disease in children and adolescents with type 1 diabetes mellitus. Int J Tuberc Lung Dis 2009; 13: 868-874.
19. Corrigal J. Is the Western Cape at risk of an outbreak of p reventable childhood diseases? Lessons from an evaluation of routine immunisation coverage. S Afr Med J 2008; 98: 41-45.
20. South African National Tuberculosis Control Programme. The South African National Tuberculosis Control Programme practical guidelines, 2004. Pretoria, South Africa: SANC, 2004. http://www.kznhealth.gov.za/chrp/documents/Guidelines/ Guidelines%20National/Tuberculosis/SA%20TB%20Guidelines %202004.pdf Accessed March 2011.
21. Van Wyk S S, Hamade H, Hesseling A C, Beyers N, Enarson D A, Mandalakas A M. Recording isoniazid preventive therapy delivery to children: operational challenges. Int J Tuberc Lung Dis 2010; 14: 650-653.
22. Carroll N M, Richardson M, van Helden P D. Criteria for identification of cross-contamination of cultures of Mycobacterium tuberculosis in routine microbiology laboratories [letter]. J Clin Microbiol 2003; 41: 2269; author reply 2269-2270. (Pubitemid 36576587)
23. Talbot E A, Williams D L, Frothingham R. PCR identification of Mycobacterium bovis BCG. J Clin Microbiol 1997; 35: 566-569. (Pubitemid 27083839)
24. Marais B J, Gie R P, Schaaf H S, et al. A proposed radiological classification of childhood intra-thoracic tuberculosis. Pediatr Radiol 2004; 34: 886-894. (Pubitemid 39462398)
25. Schoeman J F, Van Zyl L E, Laubscher J A, Donald P R. Serial CT scanning in childhood tuberculous meningitis: prognostic features in 198 cases. J Child Neurol 1995; 10: 320-329.
26. World Health Organization HIV/AIDS Programme. WHO case definitions of HIV for surveillance and revised clinical staging and immunological classification of HIV-related disease in adults and children. Geneva, Switzerland: WHO, 2007. http:// www.who.int/hiv/pub/guidelines/HIVstaging150307.pdf Accessed April 2011.
27. South African Department of Health. National antiretroviral treatment guidelines. 1st ed. Pretoria, South Africa: Department of Health, 2004. http://www.doh.gov.za/aids/index.html Accessed December 2010.
28. Department of Health, Republic of South Africa. Expanded Programme on Immunisation-EPI (SA). Revised childhood immunisation schedule from April 2009. Pretoria, South Africa: Department of Health, 2009. http://www.doh.gov.za/docs/ epi-f.html Accessed April 2011.
29. Zar H J, Cotton M F, Strauss S, et al. Effect of isoniazid prophylaxis on mortality and incidence of tuberculosis in children with HIV: randomised controlled trial. BMJ 2007; 334: 136.
30. Klugman K P, Madhi S A, Huebner R E, Kohberger R, Mbelle N, Pierce N. A trial of a 9-valent pneumococcal conjugate vaccine in children with and those without HIV infection. N Engl J Med 2003; 349: 1341-1348. (Pubitemid 37186212)
31. Gray D M, Zar H J, Cotton M F. Impact of tuberculosis preventive therapy on tuberculosis and mortality in HIV-infected children. Cochrane Database Syst Rev 2009; (1): CD006418.
32. Smith K, Kuhn L, Coovadia A, et al. Immune reconstitution inflammatory syndrome among HIV-infected South African infants initiating antiretroviral therapy. AIDS 2009; 23: 1097-1107.
33. World Health Organization HIV/AIDS Programme. Antiretroviral therapy for HIV infection in infants and children: towards universal access. Recommendations for a public health approach, 2010 revision. Geneva, Switzerland: WHO, 2010. http:// whqlibdoc.who.int/publications/2010/9789241599801-eng. pdf Accessed March 2011.
34. Yotebieng M, Van Rie A, Moultrie H, et al. Effect on mortality and virological response of delaying antiretroviral therapy initiation in children receiving tuberculosis treatment. AIDS 2010; 24: 1341-1349.
35. Violari A, Cotton M F, Gibb D M, et al. Early antiretroviral therapy and mortality among HIV-infected infants. N Engl J Med 2008; 359: 2233-2244.
36. World Health Organization. Antiretroviral therapy of HIV infection in infants and children in resource-limited settings: towards universal access. Recommendations for a public health approach. Geneva, Switzerland: WHO, 2006. http://www.who. int/hiv/pub/guidelines/WHOpaediatric.pdf Accessed March 2011.